The Detroit Tigers have lost one of their top players. Colt Keith — a left-handed hitting third baseman who also plays second base and first base — has been placed on the 10-day injured list with ...

CLEVELAND — The Detroit Tigers will be without third baseman Colt Keith in the American League wild-card series against the Cleveland Guardians. The 24-year-old remains injured with right rib cage ...

A colt by Vekoma from the family of Canadian champion Regal Intention sold for $220,000 to Mahmud Mouni to lead the Sept. 19 11th session of the Keeneland September Yearling Sale, which posted an 84% ...

The Detroit Tigers have been sliding in the standings, and although they are likely heading to the postseason, the red-hot Cleveland Guardians sit just 4.5 games behind them for first place in the AL ...

Mariners shortstop J.P. Crawford is hitting .344 (21 for 61) with two homers, four doubles and a .902 OPS since Aug. 31. Through Friday, Randy Arozarena had one hit in his previous 27 at-bats, with ...

The Detroit Tigers have to turn the page on what took place in September. After looking like they were going to walk to a division title and first-round bye, they are now facing the reality of going ...

The Tigers announced that infielder Colt Keith has been placed on the 10-day injured list due to right rib cage inflammation. Fellow infielder Jace Jung has been recalled as the corresponding move. It ...

The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T therapies, ...

Eli Manning hit the road to visit his nephew Arch’s current school, the University of Texas at Austin, for the latest episode of Eli’s Places. The finished product, “Texas Traditions: Hook ‘Em,” was ...

Detroit – The Tigers announced, less than an hour before game time Friday, that infielder Colt Keith was being placed on the 10-day injured list, ending his regular season. Keith, who left the game ...

BOSTON, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from the ...